AviadoBio Targets Rare Form Of Dementia With Gene Therapy

With Targeted Thalamus Delivery

EPC AviadoBio
Frontotemporal Dementia Causes Cognitive, Speech And Behavioral Decline • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Emerging Company Profiles

More from Start-Ups & SMEs